Modeling and Simulation to Support Phase Ib/IIa Dose Selection for WBP216, A Long Half-Life Fully Human Monoclonal Antibody Against Interleukin-6

Overview of attention for article published in Frontiers in Pharmacology, February 2021

Altmetric Badge

Citations

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in Frontiers in Immunology (February 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.